Komori
Sundrug (9989) · RiskRestated

Impact of the post-consumption-tax-increase decline in demand on sales

First written in FY2020-Q3. 6 of 8 entries say "Restated". Latest entry: FY2027-H1.

8entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q2 – FY2027-H12020: 220202021: 220212022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Sales decline due to a consumption tax increaseA theme 3 companies write about · 3 as a headwind · 0 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「No new business or other risks arose during the interim consolidated accounting period. In addition, there were no significant changes to the business and other risks described in the previous fiscal year's Annual Securities Report.」

    The company stated that there had been no material change in the risk of the post-consumption-tax-increase decline in demand affecting sales.
  2. FY2025-H1RestatedAnnual report

    「No new business or other risks arose during the interim consolidated accounting period. In addition, there were no significant changes to the business and other risks described in the previous fiscal year's Annual Securities Report.」

    The company stated that there had been no material change in the risk of the post-consumption-tax-increase decline in demand affecting sales.
  3. FY2023DroppedAnnual report
    The FY2023 text contains no identifiable reference to the impact on sales of the post-consumption-tax-increase decline in demand.
  4. FY2023-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company stated that there had been no material change in the risk of the post-consumption-tax-increase decline in demand affecting sales.
  5. FY2022-Q2RestatedAnnual report

    「During the second quarter consolidated cumulative period, there were no newly arising business or other risks. In addition, there were no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company stated that there had been no material change in the risk of the post-consumption-tax-increase decline in demand affecting sales.
  6. FY2022-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    The company stated that there had been no material change in the risk of the post-consumption-tax-increase decline in demand affecting sales.
  7. FY2021-Q2RestatedAnnual report

    「Sales fell below the year-earlier level due to the reversal of the special front-loaded demand ahead of last year's consumption-tax increase and other factors.」

    The reversal of the special front-loaded demand ahead of the consumption-tax increase continued to be a negative factor for sales in the drugstore business. A similar reversal was also reported in the discount-store business.
  8. FY2020-Q3MaterialisedAnnual report

    「Although the drugstore business faced negative factors, including weak sales of seasonal merchandise due to natural disasters and poor weather and a post-consumption-tax-increase decline in demand, it expanded its product assortment through store renovations and strengthened sales promotions. The discount-store business, like the drugstore business, also experienced weak sales of seasonal merchandise due to natural disasters and poor weather and a post-consumption-tax-increase decline in demand,」

    The post-increase reversal of front-loaded demand ahead of the consumption-tax increase was specifically recorded for the first time as an actual negative factor in both the drugstore and discount-store businesses.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sundrug yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.